Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The effects of massage therapy on multiple sclerosis patients' quality of life and leg function.
Cortical lesion load associates with progression of disability in multiple sclerosis.
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis.
The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark.
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.
Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.
Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine).
Self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis following interdisciplinary rehabilitation.
Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.
Phenytoin (Dilantin) and acupuncture therapy in the treatment of intractable oral and facial pain.
Physical Activity Behavior Change in Persons With Neurologic Disorders: Overview and Examples From Parkinson Disease and Multiple Sclerosis.
Recurrence of disease activity after repeated Natalizumab withdrawals.
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.
CLARITY – Safety and Efficacy of Oral Cladribine in Subjects with Relapsing-remitting Multiple Sclerosis (MS)
Periventricular lesions help differentiate neuromyelitis optica spectrum disorders from multiple sclerosis.
Validity and reliability of VO2-max measurements in persons with multiple sclerosis.
Santhera enters agreement with Columbia University to investigate additional potential of Catena® in MELAS
Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life.
Multiple sclerosis and progressive resistance training: a systematic review.
Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS.
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
Medicare Part D payments for neurologist-prescribed drugs.
Long-term effects of dalfampridine in patients with multiple sclerosis.
Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.

Pages